The pharma sector remains under a U.S. Section 232 investigation, with the outcome due by August.
Related Posts
Bessent to Milken conference: Trump will make America ‘more appealing for investors like you’
Treasury Secretary Scott Bessent sketched out the roadmap of President Donald Trump’s economic agenda in a pitch to a room full of global investors.
Auto giants ditch financial guidance as industry reels from Trump tariff chaos
The corporate updates come shortly after Trump imposed a 25% tariff on automotive imports into the U.S. earlier in the month.
Quantum computing firm IonQ hires former JPMorgan Chase applied research head
IonQ is one of the larger examples of pure-play quantum firms; it and competitors including Rigetti and D-Wave have seen their shares surge in the past year.